H. İ. Onen Et Al. , "EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells," HUMAN & EXPERIMENTAL TOXICOLOGY , vol.34, no.2, pp.117-126, 2015
Onen, H. İ. Et Al. 2015. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.34, no.2 , 117-126.
Onen, H. İ., Yilmaz, A., Alp, E., Celik, A., Demiroz, Ş. M., Konac, E., ... Kurul, İ. C.(2015). EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.34, no.2, 117-126.
Onen, HACER Et Al. "EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells," HUMAN & EXPERIMENTAL TOXICOLOGY , vol.34, no.2, 117-126, 2015
Onen, HACER İ. Et Al. "EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.34, no.2, pp.117-126, 2015
Onen, H. İ. Et Al. (2015) . "EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.34, no.2, pp.117-126.
@article{article, author={HACER İLKE ÖNEN Et Al. }, title={EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells}, journal={HUMAN & EXPERIMENTAL TOXICOLOGY}, year=2015, pages={117-126} }